
zzso zzso demonstrated broad spectrum activity in zzso zzso A phase 1 study utilizing twice weekly injections was conducted in 50 eligible and zzso zzso zzso patients received drug by 30 minute infusion at doses of zzso zzso and 22, by 5 minute zzso at zzso zzso The primary dose limiting zzso were zzso suppression and zzso zzso zzso was dose limiting at 75 zzso on the infusion schedule and 150 zzso on the 5 minute zzso zzso symptoms with fever, rigors and malaise occurred the day of injection in many zzso One patient with zzso cell zzso attained a partial zzso zzso of the drug's efficacy and schedule dependency zzso 

